Trump's upcoming tariffs has the potential to bring biopharma manufacturing to the US, which could impact companies with ...
Vertex halts VX-264 trials after missing efficacy goals but continues advancing zimislecel, a potential treatment for severe ...
Despite a $400 million impairment charge, analysts say the removal of a drug-device combo from its portfolio is not a huge ...
Listed 4iG group and space engineering company REMRED topped out a space technology manufacturing centre in Martonvásár, on ...
2d
Pharmaceutical Technology on MSNVertex halts development of diabetes cell therapy after trial failureVertex continues to develop type 1 diabetes therapy, zimislecel, which is being investigated in a Phase III trial.
Vertex Pharmaceuticals is flexing its innovation muscles beyond its cystic fibrosis stronghold, charging into new territories ...
Three Florida Tech students are making a mechanical 'spy' manatee to covertly learn sea cows' deepest secrets.
There’s been no shortage of either in recent weeks. Plunging valuations across the biotech sector were thrust into the ...
A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...
At the Johnson Space Center Tuesday, NASA and Firefly Aerospace held a news conference to discuss the successful Blue Ghost Mission 1.
At the Johnson Space Center Tuesday, NASA and Firefly Aerospace held a news conference to discuss the successful Blue Ghost Mission 1.
Google is diving deeper into voice AI, announcing the addition of its Chirp 3 speech-to-text and HD text-to-speech models to its Vertex AI development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results